Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Shares withheld for taxes Chief Executive Officer gave up 794 shares (to pay taxes)
  2. 4 Exercise or conversion Chief Executive Officer acquired 8,000 shares (option exercise)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Shares withheld for taxes Chief Executive Officer gave up 741 shares (to pay taxes)
  9. 4 Open-market sale Director sold 42,000 shares at $67.41 ($2,831,388)
  10. 4 Open-market sale President sold 33,618 shares at $70.00 ($2,353,260)
  11. 4 Open-market sale Director sold 7,500 shares at $62.00 ($465,000)
  12. 4 Open-market sale Director sold 7,500 shares at $55.00 ($412,500)
  13. 4 Open-market sale Director sold 7,500 shares at $52.00 ($390,000)
  14. 4 Open-market sale Director sold 21,000 shares at $51.89 ($1,089,675)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Shares withheld for taxes Chief Executive Officer gave up 740 shares (to pay taxes)
  18. 4 Shares withheld for taxes Executive VP, Head of R&D gave up 14,534 shares (to pay taxes)
  19. 4 Open-market sale Chief Business Officer sold 20,000 shares at an average $50.02 ($1,000,353)
  20. 4 Open-market sale President sold 50,000 shares at $50.00 ($2,500,065)

Page 16 of 26 · 502 filings